These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19457081)
1. Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. Hashimoto H; Hashimoto R; Shintani N; Tanaka K; Yamamoto A; Hatanaka M; Guo X; Morita Y; Tanida M; Nagai K; Takeda M; Baba A J Neurochem; 2009 Jul; 110(2):595-602. PubMed ID: 19457081 [TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Hashimoto R; Hashimoto H; Shintani N; Chiba S; Hattori S; Okada T; Nakajima M; Tanaka K; Kawagishi N; Nemoto K; Mori T; Ohnishi T; Noguchi H; Hori H; Suzuki T; Iwata N; Ozaki N; Nakabayashi T; Saitoh O; Kosuga A; Tatsumi M; Kamijima K; Weinberger DR; Kunugi H; Baba A Mol Psychiatry; 2007 Nov; 12(11):1026-32. PubMed ID: 17387318 [TBL] [Abstract][Full Text] [Related]
3. Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder. Hashimoto R; Hashimoto H; Shintani N; Ohi K; Hori H; Saitoh O; Kosuga A; Tatsumi M; Iwata N; Ozaki N; Kamijima K; Baba A; Takeda M; Kunugi H Neurosci Lett; 2010 Jan; 468(3):300-2. PubMed ID: 19914336 [TBL] [Abstract][Full Text] [Related]
4. Lack of trimethyltin (TMT)-induced elevation of plasma corticosterone in PACAP-deficient mice. Morita Y; Yanagida D; Shintani N; Ogita K; Nishiyama N; Tsuchida R; Hashimoto H; Baba A Ann N Y Acad Sci; 2006 Jul; 1070():450-6. PubMed ID: 16888208 [TBL] [Abstract][Full Text] [Related]
5. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Hashimoto H; Shintani N; Baba A Ann N Y Acad Sci; 2006 Jul; 1070():75-89. PubMed ID: 16888150 [TBL] [Abstract][Full Text] [Related]
6. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602 [TBL] [Abstract][Full Text] [Related]
7. Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors. Dhir A; Kulkarni SK Neurosci Lett; 2008 Nov; 445(1):83-8. PubMed ID: 18778754 [TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307 [TBL] [Abstract][Full Text] [Related]
9. Serotonin 5-HT(7) receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders. Tajiri M; Hayata-Takano A; Seiriki K; Ogata K; Hazama K; Shintani N; Baba A; Hashimoto H J Mol Neurosci; 2012 Nov; 48(3):473-81. PubMed ID: 22843252 [TBL] [Abstract][Full Text] [Related]
10. Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice. Ishihama T; Ago Y; Shintani N; Hashimoto H; Baba A; Takuma K; Matsuda T Behav Brain Res; 2010 Jun; 209(2):274-80. PubMed ID: 20144662 [TBL] [Abstract][Full Text] [Related]
11. Serotonergic inhibition of intense jumping behavior in mice lacking PACAP (Adcyap1-/-). Shintani N; Hashimoto H; Tanaka K; Kawagishi N; Kawaguchi C; Hatanaka M; Ago Y; Matsuda T; Baba A Ann N Y Acad Sci; 2006 Jul; 1070():545-9. PubMed ID: 16888223 [TBL] [Abstract][Full Text] [Related]
12. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Mao QQ; Ip SP; Ko KM; Tsai SH; Che CT Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1211-6. PubMed ID: 19596036 [TBL] [Abstract][Full Text] [Related]
13. [Altered behavioral response to centrally acting drugs in mice lacking PACAP]. Shintani N; Tanaka K; Hashimoto H; Baba A Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():1P-4P. PubMed ID: 14727506 [TBL] [Abstract][Full Text] [Related]
14. Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice. Hazama K; Hayata-Takano A; Uetsuki K; Kasai A; Encho N; Shintani N; Nagayasu K; Hashimoto R; Reglodi D; Miyakawa T; Nakazawa T; Baba A; Hashimoto H PLoS One; 2014; 9(2):e89153. PubMed ID: 24586556 [TBL] [Abstract][Full Text] [Related]
15. Lack of light-induced elevation of renal sympathetic nerve activity and plasma corticosterone levels in PACAP-deficient mice. Hatanaka M; Tanida M; Shintani N; Isojima Y; Kawaguchi C; Hashimoto H; Kakuda M; Haba R; Nagai K; Baba A Neurosci Lett; 2008 Oct; 444(2):153-6. PubMed ID: 18722505 [TBL] [Abstract][Full Text] [Related]
16. [Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP]. Noda Y; Nabeshima T Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):123-8. PubMed ID: 8905801 [TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of Crocin against Depression via Pituitary Adenylate Cyclase-Activating Polypeptide. Lu L; Wu D; Wang K; Tang J; Chen G Biomed Res Int; 2020; 2020():3903125. PubMed ID: 32685478 [TBL] [Abstract][Full Text] [Related]
18. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905 [TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice. Isaac ER; Sherwood NM Mol Cell Endocrinol; 2008 Jan; 280(1-2):13-9. PubMed ID: 17945412 [TBL] [Abstract][Full Text] [Related]
20. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]